Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiko Tomita

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
International Journal of Clinical Oncology|March 2, 2006
Early renal cell cancerYoshihiko Tomita
International Journal of Urology : Official Journal of the Japanese Urological Association|August 24, 2010
Editorial comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patientsYoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 7, 2014
[ I.Renal cell carcinoma]Yoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Second-line treatment of advanced renal cell carcinoma after first-line targeted therapy]Yoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[Renal cell carcinoma]Yoshihiko Tomita
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2015
Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatmentYoshihiko Tomita
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Biomarker of prostate cancer--present status and future]Akira Nagaoka, Yoshihiko Tomita
Biomedicines|November 11, 2022
Contemporary Drug Therapy for Renal Cell Carcinoma- Evidence Accumulation and Histological Implications in Treatment StrategyKazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita
Urology|May 12, 2004
Influence of androgen deprivation therapy on volume of anatomic zones of prostate in patients with prostate cancer using magnetic resonance imagingTsutomu Nishiyama, Yoshihiko Tomita, Kota Takahashi
International Journal of Urology : Official Journal of the Japanese Urological Association|May 11, 2013
Acute renal failure during the "off" period after sunitinib administration: possible mechanism of vascular endothelial growth factor cascade hyperactivationTomoyuki Kato, Yoshihiko Tomita, Tetsu Watanabe
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
International Journal of Clinical Oncology|March 2, 2006
Early renal cell cancerYoshihiko Tomita
International Journal of Urology : Official Journal of the Japanese Urological Association|August 24, 2010
Editorial comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patientsYoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 7, 2014
[ I.Renal cell carcinoma]Yoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Second-line treatment of advanced renal cell carcinoma after first-line targeted therapy]Yoshihiko Tomita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[Renal cell carcinoma]Yoshihiko Tomita
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2015
Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatmentYoshihiko Tomita
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Biomarker of prostate cancer--present status and future]Akira Nagaoka, Yoshihiko Tomita
Biomedicines|November 11, 2022
Contemporary Drug Therapy for Renal Cell Carcinoma- Evidence Accumulation and Histological Implications in Treatment StrategyKazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita
Urology|May 12, 2004
Influence of androgen deprivation therapy on volume of anatomic zones of prostate in patients with prostate cancer using magnetic resonance imagingTsutomu Nishiyama, Yoshihiko Tomita, Kota Takahashi
International Journal of Urology : Official Journal of the Japanese Urological Association|May 11, 2013
Acute renal failure during the "off" period after sunitinib administration: possible mechanism of vascular endothelial growth factor cascade hyperactivationTomoyuki Kato, Yoshihiko Tomita, Tetsu Watanabe
Pageof 22